Application GSK1838705A has been used as an insulin receptor inhibitor in Roswell Park memorial institute medium (RPMI) 1640 medium for inhibitor experiments, to prove that the induction of interleukin-1 β: (IL-1β:) is dependent on insulin
Application GSK1838705A has been used as an insulin receptor inhibitor in Roswell Park memorial institute medium (RPMI) 1640 medium for inhibitor experiments, to prove that the induction of interleukin-1 β: (IL-1β:) is dependent on insulin
Application GSK1838705A has been used as an insulin receptor inhibitor in Roswell Park memorial institute medium (RPMI) 1640 medium for inhibitor experiments, to prove that the induction of interleukin-1 β: (IL-1β:) is dependent on insulin
Application GSK1838705A has been used as an insulin receptor inhibitor in Roswell Park memorial institute medium (RPMI) 1640 medium for inhibitor experiments, to prove that the induction of interleukin-1 β: (IL-1β:) is dependent on insulin
Application CHIR 98014 has been used for the generation of small molecules neural progenitor cells and differentiation towards motor neurons. It has also been used as a Wnt/β:-catenin pharmacological agonist in the cell-conditioned medium to
Application CHIR 98014 has been used for the generation of small molecules neural progenitor cells and differentiation towards motor neurons. It has also been used as a Wnt/β:-catenin pharmacological agonist in the cell-conditioned medium to
Application CHIR 98014 has been used for the generation of small molecules neural progenitor cells and differentiation towards motor neurons. It has also been used as a Wnt/β:-catenin pharmacological agonist in the cell-conditioned medium to
Application CHIR 98014 has been used for the generation of small molecules neural progenitor cells and differentiation towards motor neurons. It has also been used as a Wnt/β:-catenin pharmacological agonist in the cell-conditioned medium to
Biochem/physiol Actions GAT229 is the S-(-)-enantiomer of GAT211, a positive allosteric modulator (PAM) of cannabinoid CB1 receptor signaling that was found to amplify the therapeutic effect of endocannabinoids without the negative side effects of
Biochem/physiol Actions GAT229 is the S-(-)-enantiomer of GAT211, a positive allosteric modulator (PAM) of cannabinoid CB1 receptor signaling that was found to amplify the therapeutic effect of endocannabinoids without the negative side effects of
Biochem/physiol Actions GAT229 is the S-(-)-enantiomer of GAT211, a positive allosteric modulator (PAM) of cannabinoid CB1 receptor signaling that was found to amplify the therapeutic effect of endocannabinoids without the negative side effects of
Biochem/physiol Actions GAT229 is the S-(-)-enantiomer of GAT211, a positive allosteric modulator (PAM) of cannabinoid CB1 receptor signaling that was found to amplify the therapeutic effect of endocannabinoids without the negative side effects of
Biochem/physiol Actions Potent and selective pan-aurora kinase inhibitor that binds aurora kinase in the DFG-in conformation and exhibits anticancer efficacy in vitro and in vivo . SNS-314 is a potent pan-aurora kinases inhibitor (IC50 =
Biochem/physiol Actions Potent and selective pan-aurora kinase inhibitor that binds aurora kinase in the DFG-in conformation and exhibits anticancer efficacy in vitro and in vivo . SNS-314 is a potent pan-aurora kinases inhibitor (IC50 =
Biochem/physiol Actions Potent and selective pan-aurora kinase inhibitor that binds aurora kinase in the DFG-in conformation and exhibits anticancer efficacy in vitro and in vivo . SNS-314 is a potent pan-aurora kinases inhibitor (IC50 =
Biochem/physiol Actions Potent and selective pan-aurora kinase inhibitor that binds aurora kinase in the DFG-in conformation and exhibits anticancer efficacy in vitro and in vivo . SNS-314 is a potent pan-aurora kinases inhibitor (IC50 =
Biochem/physiol Actions MGR1 is an effective reactive oxygen species (ROS) generator in live cells (dosing range 2-100 μ:M). MGR1 is activated by intracellular esterases to form JCHD
Biochem/physiol Actions MGR1 is an effective reactive oxygen species (ROS) generator in live cells (dosing range 2-100 μ:M). MGR1 is activated by intracellular esterases to form JCHD
Biochem/physiol Actions MGR1 is an effective reactive oxygen species (ROS) generator in live cells (dosing range 2-100 μ:M). MGR1 is activated by intracellular esterases to form JCHD
Biochem/physiol Actions MGR1 is an effective reactive oxygen species (ROS) generator in live cells (dosing range 2-100 μ:M). MGR1 is activated by intracellular esterases to form JCHD